Header cover image

German Biotech Breakthroughs

Results

1

0 new

Biotech stocks worldwide which are expected to become profitable in the next 3 years.

1 companies

Formycon

Market Cap: €411.6m

A biotechnology company, develops biosimilar drugs in Germany and Switzerland.

FYB

€22.55

7D

-1.7%

1Y

-57.2%